EIDD-2810

Should Merck’s COVID Pill Be Granted Emergency Use Authorization?

There are now two direct-acting antiviral drugs that have been shown to decrease the severity of COVID, Gilead's remdesivir and Merck's molnupiravir.

Back in April, I wrote about EIDD-2801, now called molnupiravir, (1) at which time I wr